NTRA News and Press, Natera Inc. From 06/18/20

SAN CARLOS, Calif. , June 18, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that enrollment has begun in the CIRCULATE-Japan and BESPOKE CRC trials, with both studies experiencing strong interest from centers ac...

SAN CARLOS, Calif. , June 17, 2020 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a global leader in cell-free DNA testing, filed suit today against Progenity, Inc. for infringing six patents: U.S. Patents  9,228,234; 9,424,392; 10,227,652; 10,240,202; 10,266,893; and 10,...

Progenity ( PROG ) has filed a prospectus for its IPO of ~6.7M common shares at $14 - 16 per share. Gross proceeds should be ~$100M (midpoint). More news on: Progenity, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Healthcare stocks news, IPO News, , ...

Quick Take Progenity ( PROG ) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement . The firm is commercializing molecular testing products to maximize the ability to personalize disease treatments. PROG is dealing with the temporary ...

SAN CARLOS, Calif. , June 1, 2020 /PRNewswire/ --   Natera, Inc.  (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, is pleased to announce the launch of a novel technique to enhance results from the Prospera donor-derived cell-free DNA (dd-cfDNA) transplan...

SAN CARLOS, Calif. , May 26, 2020 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its Prospera donor-derived cell-free DNA (dd-cfDNA) transplant assessment test at the 2020 Amer...

SAN CARLOS, Calif. , May 19, 2020 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, and its collaborators will present new data demonstrating the clinical validity and utility of its personalized molecular residual disease (MR...

SAN CARLOS, Calif. and SAN DIEGO , May 18, 2020 /PRNewswire/ --  Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, and Illumina Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing platforms, today announced that they have settled the...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

SAN CARLOS, Calif. , May 13, 2020 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast a live presentation at the UBS Virtual Global Healthcare Conference on Monday, May 18, 2020 ...